Durvalumab(D) +/- tremelimumab(T) plus platinum-etoposide(EP) in 1L ES-SCLC: Characterization of long-term benefit in CASPIAN


Saito H., Goldman J. W. , Garassino M. C. , Chen Y., Reinmuth N., Hotta K., ...More

ANNALS OF ONCOLOGY, vol.32, 2021 (Journal Indexed in SCI) identifier

  • Publication Type: Article / Abstract
  • Volume: 32
  • Publication Date: 2021
  • Doi Number: 10.1016/j.annonc.2021.05.537
  • Title of Journal : ANNALS OF ONCOLOGY